INTERNATIONAL PATENT: VIVIDION THERAPEUTICS, INC. FILES APPLICATION FOR "(E)-2-(BENZYLAMINO)-N-(3-(METHYLSULFONYL)ALLYL)-BENZAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS JAK1 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES OR CANCER"

GENEVA, March 10 -- VIVIDION THERAPEUTICS, INC. (5820 Nancy Ridge DriveSan Diego, CA 92121) filed a patent application (PCT/US2024/044474) for "(E)-2-(BENZYLAMINO)-N-(3-(METHYLSULFONYL)ALLYL)-BENZAMIDE DERIVATIVES AND SIMILAR COMPOUNDS AS JAK1 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISEASES, AUTOIMMUNE DISEASES OR CANCER" on Aug 29, 2024. With publication no. WO/2025/049774, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): KIKUCHI, Shota (5820 Nancy Ridge DriveSan Diego, CA 92121), HORNING, Benjamin (5820 Nancy Ridge...